Skip to main content
. Author manuscript; available in PMC: 2013 Dec 15.
Published in final edited form as: Bioorg Med Chem. 2012 Oct 23;20(24):6940–6944. doi: 10.1016/j.bmc.2012.10.012

Table 2.

Antiproliferative activity of compounds 1–3 and synthetic intermediates 7–12 against A2780 ovarian cancer cells.

Compound IC50 (µ M)
1 10.2 ± 0.9
2 5.5 ± 0.9
rac-2 5.9 ± 0.7
3 6.7 ± 0.3
rac-3 6.3 ± 0.4
7 >50
8 >50
9 33.9 ± 1.5
10 4.0 ± 0.5
11 22.1 ± 3.4
12 35.5 ± 2.7
Paclitaxel 0.028±
0.003